Full text is available at the source.
Abstract
A rapid review of literature indicates that ketamine may be used for pain and depression management in patients with metastatic cancer.
- Ketamine is being explored for its potential benefits in alleviating pain associated with metastatic cancer.
- This review highlights the role of ketamine in addressing depression symptoms in cancer patients.
- The findings suggest that palliative care providers may consider ketamine as an additional tool for symptom management.
- The review focuses on existing studies, emphasizing the need for further investigation into ketamine's efficacy in palliative care.
Simplified